Article

EyeRide for Sight is under way and taking donations

A cycling team began a 3,000-mile transcontinental bike ride on May 7 in order to educate the public about eye disease and raise funds to support EyeCare America's efforts to save sight.

San Francisco-A cycling team made up of six cyclists from the United Kingdom began a 3,000-mile transcontinental bike ride on May 7 in order to educate the public about eye disease, encourage the public to utilize EyeCare America's free eye-care programs, and raise funds to support this public service program of the Foundation of the American Academy of Ophthalmology's (AAO) efforts to save sight.

 

"When our board member, Tony McClellan, approached us to let us know that his son was looking for a worthy cause to support during his scheduled transcontinental bike ride, we thought that it would be a great partnership," said Richard P. Mills, MD, chairman of EyeCare America. "Through the EyeRide for Sight, we hope to get the message out to medically underserved communities that EyeCare America can help save their sight."

California Governor Arnold Schwarzenegger sent a letter of support to the California based organization for the journey that began at EyeCare America's headquarters in San Francisco and will finish at the AAO's Washington, DC office in late July. Another supporter of the ride is the California Academy of Eye Physicians and Surgeons.

The EyeRide for Sight cycling team is led by Tom McClellan of Gloucestershire, South West England, and the riders are McClellan, Alex Galvin, Ben Hodge, Ben Leigh, Oliver Lombard, and Fred Mahon.

"We are excited to work with EyeCare America in order to help raise awareness about eye disease and preventable blindness," said McClellan. "We hope that our bike ride across the United States will allow EyeCare America to help even more people save their sight."

A $25 donation provides free medical eye care to someone in need within the United States. To make a donation log on to www.eyecareamerica.org , and click on the "EyeRide for Sight" logo.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.